Pitfalls of the application of microdialysis in clinical oncology: Controversial findings with docetaxel

W. J. Loos*, W. C. Zamboni, F. K. Engels, P. de Bruijn, M. H. Lam, R. de Wit, J. Verweij, E. A. C. Wiemer

*Corresponding author voor dit werk

Onderzoeksoutput: ArticleAcademicpeer review

20 Citaten (Scopus)

Samenvatting

Microdialysis is a novel and minimally invasive sampling technique, based on the diffusion of analytes from the interstitial compartment through a semi-permeable membrane, and enables direct assessment of tissue disposition and penetration of drugs. Variable antitumor responses may be associated with differences in tumor vascularity, capillary permeability or tumor interstitial pressure resulting in variable delivery of anticancer agents. In preparation of pharmacokinetic studies, aimed at measuring docetaxel concentrations in healthy and malignant tissues in vivo, in preclinical as well as clinical studies, in vitro recovery experiments were performed. In contrast to published data, the recovery experiments suggest that docetaxel has a very low recovery as a result of non-specific binding to currently available microdialysis catheters. Here we discuss our findings with docetaxel in a historical perspective and we report on our experience using polysorbate 80 to eliminate the non-specific binding and its effects on the recovery of docetaxel. (c) 2007 Elsevier B.V. All rights reserved.

Originele taal-2English
Pagina's (van-tot)288-294
Aantal pagina's7
TijdschriftJournal of Pharmaceutical and Biomedical Analysis
Volume45
Nummer van het tijdschrift2
DOI's
StatusPublished - 18-okt.-2007

Vingerafdruk

Duik in de onderzoeksthema's van 'Pitfalls of the application of microdialysis in clinical oncology: Controversial findings with docetaxel'. Samen vormen ze een unieke vingerafdruk.

Citeer dit